Advertisement

Breast Cancer Research and Treatment

, Volume 79, Issue 3, pp 313–320 | Cite as

Growth and Fatty Acid Metabolism of Human Breast Cancer (MCF-7) Xenografts in Nude Rats: Impact of Constant Light-Induced Nocturnal Melatonin Suppression

  • David E. Blask
  • Robert T. Dauchy
  • Leonard A. Sauer
  • Jean A. Krause
  • George C. Brainard
Article

Abstract

The nocturnal melatonin (MLT) surge is a relevant oncostatic signal for a variety of experimental malignancies. Population studies support the hypothesis that exposure to light at night may represent a new risk factor for breast cancer possibly through the suppression of pineal MLT production and/or circadian disruption. We tested the ability of constant light exposure to suppress MLT production in female nude rats and stimulate the growth of tissue-isolated MCF-7 human breast cancer xenografts via increased tumor linoleic acid (LA) metabolism. Rats maintained on an alternating light/dark cycle (L:D group) exhibited a robust circadian MLT rhythm that was abolished following constant light exposure. During the exposure of animals bearing tissue-isolated human MCF-7 breast cancer xenografts to constant light, the rate of tumor growth markedly increased relative to the L:D group. Tumor LA uptake and its metabolism to the mitogen 13-hydroxyoctadecadienoic acid (13-HODE) were also substantially higher under constant light conditions. This is the first biological evidence for a potential link between constant light exposure and increased human breast oncogenesis involving MLT suppression and stimulation of tumor LA metabolism.

circadian disruption constant light fatty acids MCF-7 human breast cancer xenografts melatonin pineal gland 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reiter RJ: Melatonin: a multifaceted messenger to the masses. Lab Med 25: 438-441, 1994.Google Scholar
  2. 2.
    Cassone VM: The pineal gland influences rat circadian activity rhythms in constant light. J Biol Rhythms 7: 27-40, 1992Google Scholar
  3. 3.
    Brainard GC, Richardson BA, King TS, Reiter RJ: The in-fluence of different light spectra on the suppression of pineal melatonin content in the Syrian hamster. Brain Res 294: 333-339, 1984Google Scholar
  4. 4.
    Brainard GC, Richardson BA, King TS, Matthews SA, Reiter RJ: The suppression of pineal melatonin content and Nacetyltransferase activity by different light irradiances in the Syrian hamster: a dose-response relationship. Endocrinology 113: 293-296, 1983Google Scholar
  5. 5.
    Minneman KP, Lynch H, Wurtman: Relationship between environmental light intensity and retina-mediated suppression of rat pineal serotonin-N-acetyltransferase. Life Sci 15: 1791-1796, 1974Google Scholar
  6. 6.
    Reiter RJ, Hurlbut EC, Brainard GC, Steinlechner S, Richardson BA: Influence of light irradiance on hydroxyindole-O-methyltransferase activity, serotonin-N-acetyltransferase activity, and radioimmunoassayable melatonin levels in the pineal gland of the diurnally active Richardson's Ground Squirrel. Brain Res 288: 151-157, 1983Google Scholar
  7. 7.
    Blask DE: An overview of the neuroendocrine regulation of experimental tumor growth by melatonin and its analogues and the therapeutic use of melatonin in oncology. In: Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke D (eds) The Pineal Gland and Cancer. Springer, Berlin, 2001, pp 309-342Google Scholar
  8. 8.
    Blask DE, Sauer LA, Dauchy RT: Melatonin as a chronobiotic/ anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadianbased cancer therapy. Curr Top Med Chem 2:113-132, 2002Google Scholar
  9. 9.
    Hill SM, Keifer T, Teplitzky S, Spriggs LL, Ram P: Modulation of the estrogen response pathway in human breast cancer cells by melatonin. In: Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke D (eds) The Pineal Gland and Cancer. Springer, Berlin, 2001, pp 343-358Google Scholar
  10. 10.
    Jöchle W: Trends in photophysiologic concepts. Ann NY Acad Sci 117: 88-104, 1964Google Scholar
  11. 11.
    Kothari L, Shah PN, Mhatre MC: Pineal ablation in varying photoperiods and the incidence of 9,10-dimethyl-1, 2-benzanthracene-induced mammary cancer in rats. Cancer Lett 22: 99-102, 1984Google Scholar
  12. 12.
    Kothari L: Influence of chronic melatonin on 9,10-dimethyl-1, 2-benzanthracene-induced mammary tumors in female Holtzman rats exposed to continuous light. Oncology 44: 64-66, 1987Google Scholar
  13. 13.
    Anderson LE, Morris JE, Sasser LB, Stevens RG: Effect of constant light on DMBA mammary tumorigenesis in rats. Cancer Lett 148: 121-126, 2000Google Scholar
  14. 14.
    Stevens RG: Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125: 556-561, 1987Google Scholar
  15. 15.
    Hansen J: Increased breast cancer risk among women who work predominantly at night. Epidemiology 12: 74-77, 2001Google Scholar
  16. 16.
    Davis S, Mirick DK, Stevens RG: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93: 1557-1562, 2001Google Scholar
  17. 17.
    Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA: Rotating night shifts and risk of breast cancer in women participating in the nurse's health study. J Natl Cancer Inst 93: 1563-1568, 2001Google Scholar
  18. 18.
    Hahn RA: Profound bilateral blindness and the incidence of breast cancer. Epidemiology 2: 208-210, 1991Google Scholar
  19. 19.
    Feychting M, Ústerland B, Ahlbom A: Reduced cancer incidence among the blind. Epidemiology 9: 490-494, 1998Google Scholar
  20. 20.
    Verkasalo P, Pukkala E, Stevens RG, Ojama, Rudanko S-L: Visual impairment and cancer: a population-based cohort study in Finland. Cancer Causes and Control 10: 13-20, 1999Google Scholar
  21. 21.
    Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, Defrance R: Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metabiol 82: 3763-3770, 1997Google Scholar
  22. 22.
    Stevens RG, Rea MS: Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12: 279-287, 2001Google Scholar
  23. 23.
    Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS: Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res 59: 4693-470, 1999Google Scholar
  24. 24.
    Dauchy RT, Blask DE, Sauer LA, Vaughan GM: Light contamination during the dark phase in ‘photoperiodicallycontrolled’ animal rooms: effect on tumor growth and metabolism in rats. Lab Anim Sci 47: 511-518, 1997Google Scholar
  25. 25.
    Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA: Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 144: 131-136, 1999Google Scholar
  26. 26.
    Folch JM, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-507, 1957Google Scholar
  27. 27.
    McDonald-Gibson RG: Quantitative measurements of arachidonic acid in tissues or fluids. In: Benedetto C, McDonald-Gibson RG, Nigam S, Slater TF (eds) Prostaglandins and Related Substances. IRL Press, Washington, pp 259-268, 1987Google Scholar
  28. 28.
    Tamarkin L, Danforth D, Lichter E, DeMoss M, Cohen M, Chabner B, Lippman M: Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science 216: 1003-1005, 1983Google Scholar
  29. 29.
    Hayashi K, Okatani Y: Mechanisms underlying the effects of estrogen on nocturnal melatonin synthesis in peripubertal female rats: relation to norepinephrine and adenylate cyclase. J Pineal Res 26: 178-183, 1999Google Scholar
  30. 30.
    Osborne CK, Hobbs K, Clark GM: Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45: 584-590, 1985Google Scholar
  31. 31.
    Ram PT, Yuan L, Dai J, Kiefer T, Klotz DM, Spriggs LL, Hill SM: Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin. J Pineal Res 28: 210-218, 2000Google Scholar
  32. 32.
    Liu X-H, Connolly JM, Rose DP: The 12-lipoxygenase genetransfected MCF-7 human breast cancer cell line exhibits estrogen-independent, but estrogen and omega-6 fatty acidstimulated proliferation in vitro, and enhanced growth in athymic nude mice. Cancer Lett 109: 223-230, 1996Google Scholar
  33. 33.
    Reiter RJ: The pineal gland, melatonin and reproduction. In: Bittar EE, Bittar N (eds) Principles of Medical Biology. Vol 12, JAI Press, Greenwich, 1998, pp 141-154Google Scholar
  34. 34.
    Mhatre MC, Shah PN, Juneja HS: Effect of varying photoperiods on mammary morphology, DNA synthesis, and hormone profile in female rats. J Natl Cancer Inst 72: 141-1415, 1984Google Scholar
  35. 35.
    Shah PN, Mhatre MC, Kothari LS: Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res 44: 3403-3407, 1984Google Scholar
  36. 36.
    Seshadri R, Subramanian A, Kothari LS: Effect of neonatal pineal ablation on estradiol receptors in mammary glands of rats housed under varying photoperiods. Indian J Exp Biol 30: 162-164, 1992Google Scholar
  37. 37.
    Graham GC, Cook MR, Gerkovich MM, Sastre A: Examination of the melatonin hypothesis in women exposed at night to EMF or bright light. Environ Health Perspect 109: 501-507, 2001Google Scholar
  38. 38.
    Depres-Bummer P, Levi F, Metzger G, Touitou Y: Lightinduced suppression of the rat circadian system. Am J Physiol 268: R1111-R1116, 1995Google Scholar
  39. 39.
    Dillon DC, Easley SE, Asch BB, Cheney RT, Brydon L, Jockers R, Winston JS, Brooks JS, Hurd T, Asch HL: Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am J Clin Pathol 118: 451-458, 2002Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • David E. Blask
    • 1
  • Robert T. Dauchy
    • 1
  • Leonard A. Sauer
    • 1
  • Jean A. Krause
    • 1
  • George C. Brainard
    • 2
  1. 1.Laboratory of Chrono-Neuroendocrine OncologyBassett Research InstituteCooperstownUSA
  2. 2.Department of Neurology, Jefferson Medical CollegeThomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations